WallStSmart
MHUA

Meihua International Medical Technologies Co Ltd

NASDAQ: MHUA · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$7.61
+0.00% today

Updated 2026-06-03

Market cap
$425.43M
P/E ratio
0.25
P/S ratio
4.75x
EPS (TTM)
$31.00
Dividend yield
52W range
$2 – $64
Volume
0.1M

Meihua International Medical Technologies Co Ltd (MHUA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 7
Last 7 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
+56.6%
Most recent quarter
EPS YoY growth
-65.5%
Most recent quarter

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-5.5%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-5.5%
2025-09-18
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-09-18$0.10$0.42$0.40-5.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-06-30$0.10$37.98M-16.2%
2025-03-31$0.00$0.19$18.99M
2024-06-30$0.00$0.17$45.34M
2023-03-31$0.00$0.27$24.10M
2022-09-30$0.00$0.29$24.26M
2021-06-30$0.00$0.83
2020-09-30$0.00$0.51

Frequently asked questions

Has Meihua International Medical Technologies Co Ltd beaten earnings estimates?

Meihua International Medical Technologies Co Ltd has beaten Wall Street EPS estimates in 6 of its last 7 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.

How does MHUA stock react to earnings?

MHUA has moved an average of -5.5% the day after earnings over its last 1 reports, finishing higher after 0 of them. Next-day moves show how the market digests results in the short term, and repeated dips on strong reports usually mean expectations were already priced in.

What is Meihua International Medical Technologies Co Ltd's revenue growth rate?

Meihua International Medical Technologies Co Ltd reported year-over-year revenue growth of +56.6% in its most recent quarter, with EPS up -65.5%. Reading revenue growth alongside margins shows whether that growth is translating into profit.